Daptomycin non-susceptible Staphylococcus aureus at a US medical centre

Nailor, 2011, Antibiotics for gram‐positive bacterial infection: vancomycin, teicoplanin, quinupristin/dalfopristin, oxazolidinones, daptomycin, telavancin, and ceftaroline, Med Clin North Am, 95, 723, 10.1016/j.mcna.2011.03.011 Sader, 2011, Antimicrobial susceptibility of daptomycin and comparator agents tested again methicillin‐resistant Staphylococcus aureus and vancomycin‐resistant enterococci: trend analysis of a 6‐year period in US medical centers (2005–2010), Diagn Microbiol Infect Dis, 70, 412, 10.1016/j.diagmicrobio.2011.02.008 Picazo, 2011, Staphylococcus aureus resistente a meticilina:sensibilidad a la daptomicina a lo largo de un periodo de 10 anos (2001–2010), Rev Esp Quimioter, 24, 107 Richter, 2011, Activity of ceftaroline and epidemiologic trends in Staphylococcus aureus isolates collected from 43 medical centers in the United States in 2009, Antimicrob Agents Chemother, 55, 4154, 10.1128/AAC.00315-11 Nannini, 2010, Resistance or decreased susceptibility to glycopeptides, daptomycin, linezolid in methicillin‐resistant Staphylococcus aureus, Curr Opin Pharmacol, 10, 516, 10.1016/j.coph.2010.06.006 Fischer, 2011, Daptomycin resistance mechanisms in clinically derived Staphylococcus aureus strains assessed by a combined transcriptomics and proteomics approach, J Antimicrob Chemother, 66, 1696, 10.1093/jac/dkr195 Bertsche, 2011, Correlation of daptomycin resistance in a clinical Staphylococcus aureus strain with increased cell wall teichoic acid production and D‐alanylation, Antimicrob Agents Chemother, 55, 3922, 10.1128/AAC.01226-10 Boyle‐Vavra, 2011, Comparative genome sequencing of an isogenic pair of USA800 clinical methicillin‐resistant Staphylococcus aureus isolates obtained before and after daptomycin treatment failure, Antimicrob Agents Chemother, 55, 2018, 10.1128/AAC.01593-10 Fowler, 2006, Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus, N Engl J Med, 355, 653, 10.1056/NEJMoa053783 Goering, 2011, Pulsed‐field gel electrophoresis laboratory and epidemiologic considerations for interpretation of data, 167 Enright, 2000, Multilocus sequence typing for characterization of methicillin‐resistant and methicillin‐ susceptible clones of Staphylococcus aureus, J Clin Microbiol, 38, 1008, 10.1128/JCM.38.3.1008-1015.2000 Van Hal, 2011, Emergence of daptomycin resistance following vancomycin‐unresponsive Staphylococcus aureus bacteremia in a daptomycin‐naïve patient – a review of the literature, Eur J Clin Microbiol Infect Dis, 30, 603, 10.1007/s10096-010-1128-3 Dhand, 2011, Use of antistaphylococcal B‐lactams to increase daptomycin activity in eradicating persistent bacteremia due to methicillin‐resistant Staphylococcus aureus: role of enhanced daptomycin binding, Clin Infect Dis, 53, 158, 10.1093/cid/cir340 Mehta, 2012, B‐Lactams increase the antibacterial activity of daptomycin against clinical methicillin‐resistant Staphylococcus aureus strains and prevent selection of daptomycin‐resistant derivatives, Antimicrob Agents Chemother, 56, 6192, 10.1128/AAC.01525-12 Yang, 2010, Daptomycin‐oxacillin combinations in treatment of experimental endocarditis caused by daptomycin‐nonsusceptible strains of methicillin‐resistant Staphylococcus aureus with evolving oxacillin susceptibility (the “seesaw effect”), Antimicrob Agents Chemother, 54, 3161, 10.1128/AAC.00487-10